Literature DB >> 14736496

Evaluation of toxic equivalency factors for induction of cytochromes P450 CYP1A1 and CYP1A2 enzyme activity by dioxin-like compounds.

Hiroyoshi Toyoshiba1, Nigel J Walker, A John Bailer, Christopher J Portier.   

Abstract

The toxic equivalency factor (TEF) method has been used to characterize the toxicity of human mixtures of dioxin-like compounds and is being considered for use with other classes of potentially toxic agents. TEFs are estimated by examining the relative potencies of the various congeners for a series of biological and toxicological effects. In this paper, we consider changes in activity for two enzymes, cytochrome P450 1A1 (CYP1A1)-associated 7-ethoxyresorufin-O-deethylase (EROD) and CYP1A2-associated acetanilide-4-hydroxylase (A4H) activity, resulting from exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), 3,3',4,4',5-pentachlorobiphenyl (PCB), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) or a mixture of these agents. The ratio of median effective dose (ED50) is one way to estimate the relative potencies, especially for gene expression and protein endpoints. ED50's were estimated with a nonlinear regression model in which dose-related changes in mean responses are described by a Hill function. ED50's along with other model parameters were estimated by fitting this model to a given data set. Significant differences in estimated model parameters were tested by likelihood ratio methods. The estimated parameters indicated that congener-specific dose-response shapes were significantly different, that additivity failed for these congeners, and that the ratios of ED50's did not predict the response seen for the mixture. These results indicate that for some biological responses, the use of a single relative potency factor (RPF) is not appropriate for the comparison of the dose response behavior of different dioxin-like congeners.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14736496     DOI: 10.1016/j.taap.2003.09.015

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  16 in total

1.  Comparison of chronic toxicity and carcinogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in 2-year bioassays in female Sprague-Dawley rats.

Authors:  Nigel J Walker; Michael E Wyde; Lawrence J Fischer; Abraham Nyska; John R Bucher
Journal:  Mol Nutr Food Res       Date:  2006-10       Impact factor: 5.914

2.  A simple procedure for estimating pseudo risk ratios from exposure to non-carcinogenic chemical mixtures.

Authors:  Franco Scinicariello; Christopher Portier
Journal:  Arch Toxicol       Date:  2015-02-11       Impact factor: 5.153

Review 3.  Advances in analytical techniques for polychlorinated dibenzo-p-dioxins, polychlorinated dibenzofurans and dioxin-like PCBs.

Authors:  Eric J Reiner; Ray E Clement; Allan B Okey; Chris H Marvin
Journal:  Anal Bioanal Chem       Date:  2006-06-23       Impact factor: 4.142

4.  Dose-response modeling of high-throughput screening data.

Authors:  Fred Parham; Chris Austin; Noel Southall; Ruili Huang; Raymond Tice; Christopher Portier
Journal:  J Biomol Screen       Date:  2009-12

5.  A novel contact assay for testing aryl hydrocarbon receptor (AhR)-mediated toxicity of chemicals and whole sediments in zebrafish (Danio rerio) embryos.

Authors:  Sabrina Schiwy; Jennifer Bräunig; Henriette Alert; Henner Hollert; Steffen H Keiter
Journal:  Environ Sci Pollut Res Int       Date:  2014-06-25       Impact factor: 4.223

6.  Repeated dose toxicity and relative potency of 1,2,3,4,6,7-hexachloronaphthalene (PCN 66) 1,2,3,5,6,7-hexachloronaphthalene (PCN 67) compared to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) for induction of CYP1A1, CYP1A2 and thymic atrophy in female Harlan Sprague-Dawley rats.

Authors:  Michelle J Hooth; Abraham Nyska; Laurene M Fomby; Daphne Y Vasconcelos; Molly Vallant; Michael J DeVito; Nigel J Walker
Journal:  Toxicology       Date:  2012-07-17       Impact factor: 4.221

Review 7.  The 2005 World Health Organization reevaluation of human and Mammalian toxic equivalency factors for dioxins and dioxin-like compounds.

Authors:  Martin Van den Berg; Linda S Birnbaum; Michael Denison; Mike De Vito; William Farland; Mark Feeley; Heidelore Fiedler; Helen Hakansson; Annika Hanberg; Laurie Haws; Martin Rose; Stephen Safe; Dieter Schrenk; Chiharu Tohyama; Angelika Tritscher; Jouko Tuomisto; Mats Tysklind; Nigel Walker; Richard E Peterson
Journal:  Toxicol Sci       Date:  2006-07-07       Impact factor: 4.849

8.  Characterizing non-constant relative potency.

Authors:  Gregg E Dinse; David M Umbach
Journal:  Regul Toxicol Pharmacol       Date:  2011-05-13       Impact factor: 3.271

9.  Generalized concentration addition predicts joint effects of aryl hydrocarbon receptor agonists with partial agonists and competitive antagonists.

Authors:  Gregory J Howard; Jennifer J Schlezinger; Mark E Hahn; Thomas F Webster
Journal:  Environ Health Perspect       Date:  2010-05       Impact factor: 9.031

10.  Generalized concentration addition: a method for examining mixtures containing partial agonists.

Authors:  Gregory J Howard; Thomas F Webster
Journal:  J Theor Biol       Date:  2009-04-05       Impact factor: 2.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.